<p>Unstimulated (<i>grey</i>) and PMA/ionomycin stimulated (<i>white</i>) blood samples were stained for the expression of NFATc1 in CD3<sup>+</sup> (<i>upper left graph</i>), CD4<sup>+</sup> (<i>upper middle graph</i>), CD8<sup>+</sup> (<i>upper right graph</i>), CD4<sup>+</sup>CD28<sup>+</sup> (<i>lower left graph</i>), CD8<sup>+</sup>CD28<sup>+</sup> (<i>lower middle graph</i>) and CD8<sup>+</sup>CD28<sup>-</sup> (<i>lower right graph</i>) T cells. Data are plotted as box and whiskers (Tukey style); n = 23 isotype controls, n = 10 healthy controls, n = 11 TAC patients before transplantation; *) p < 0.05, **) p < 0.01, ***) p < 0.001.</p
<p>The total CD3+ T cell population was acquired by MACS isolation of PBMC from healthy volunteers. ...
The calcineurin inhibitor, tacrolimus (TAC), inhibits the protein phosphatase activity of calcineuri...
<p>PBMC from healthy donors and TSC subjects were isolated by density gradient centrifugation, count...
<p>(A) NFATc1 amplification in CD4<sup>+</sup>CD28<sup>+</sup>, CD8<sup>+</sup>CD28<sup>+</sup> and ...
<p>TAC, at a high concentration of 50 ng/ml, significantly inhibited the expression of NFATc1 in bot...
<p>(A) Gating of CD3<sup>+</sup> T cell subsets. Cells were gated for their expression of CD14 and C...
<div><p>Background</p><p>Therapeutic drug monitoring (TDM) of tacrolimus, based on blood concentrati...
BACKGROUND:Therapeutic drug monitoring (TDM) of tacrolimus, based on blood concentrations, shows an ...
<p>The immune suppressants cyclosporin A (CsA) and tacrolimus (FK506) are used worldwide in transpla...
<p>CD3+ T cells were acquired by MACS isolation of PBMC from healthy volunteers. Cells were anti-CD3...
<p>A, Representative FACS profile of MAIT cells and NKG2D expression in total, CD8<sup>+</sup>, and ...
The immune suppressants cyclosporin A (CsA) and tacrolimus (FK506) are used worldwide in transplanta...
Umbilical cord blood (UCB) stem cells from related and unrelated allogeneic donors have emerged as n...
textabstractThe calcineurin inhibitor, tacrolimus (TAC), inhibits the protein phosphatase activity o...
Flow-cytometry analysis of healthy donor and patients PBMC following three days of PMA/ionomycin sti...
<p>The total CD3+ T cell population was acquired by MACS isolation of PBMC from healthy volunteers. ...
The calcineurin inhibitor, tacrolimus (TAC), inhibits the protein phosphatase activity of calcineuri...
<p>PBMC from healthy donors and TSC subjects were isolated by density gradient centrifugation, count...
<p>(A) NFATc1 amplification in CD4<sup>+</sup>CD28<sup>+</sup>, CD8<sup>+</sup>CD28<sup>+</sup> and ...
<p>TAC, at a high concentration of 50 ng/ml, significantly inhibited the expression of NFATc1 in bot...
<p>(A) Gating of CD3<sup>+</sup> T cell subsets. Cells were gated for their expression of CD14 and C...
<div><p>Background</p><p>Therapeutic drug monitoring (TDM) of tacrolimus, based on blood concentrati...
BACKGROUND:Therapeutic drug monitoring (TDM) of tacrolimus, based on blood concentrations, shows an ...
<p>The immune suppressants cyclosporin A (CsA) and tacrolimus (FK506) are used worldwide in transpla...
<p>CD3+ T cells were acquired by MACS isolation of PBMC from healthy volunteers. Cells were anti-CD3...
<p>A, Representative FACS profile of MAIT cells and NKG2D expression in total, CD8<sup>+</sup>, and ...
The immune suppressants cyclosporin A (CsA) and tacrolimus (FK506) are used worldwide in transplanta...
Umbilical cord blood (UCB) stem cells from related and unrelated allogeneic donors have emerged as n...
textabstractThe calcineurin inhibitor, tacrolimus (TAC), inhibits the protein phosphatase activity o...
Flow-cytometry analysis of healthy donor and patients PBMC following three days of PMA/ionomycin sti...
<p>The total CD3+ T cell population was acquired by MACS isolation of PBMC from healthy volunteers. ...
The calcineurin inhibitor, tacrolimus (TAC), inhibits the protein phosphatase activity of calcineuri...
<p>PBMC from healthy donors and TSC subjects were isolated by density gradient centrifugation, count...